🐜
|
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
30 auth.
U. Hüffmeier,
S. Uebe,
A. Ekici,
J. Bowes,
E. Giardina,
E. Korendowych,
K. Juneblad,
Maria Apel,
R. McManus,
P. Ho,
I. Bruce,
A. Ryan,
F. Behrens,
J. Lascorz,
B. Böhm,
...
H. Traupe,
J. Lohmann,
C. Gieger,
H. Wichmann,
C. Herold,
M. Steffens,
L. Klareskog,
T. Wienker,
O. FitzGerald,
G. Alenius,
N. McHugh,
G. Novelli,
H. Burkhardt,
A. Barton,
A. Reis
|
8 |
2010 |
8 🐜
|
🐜
|
Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
32 auth.
J. Bowes,
A. Budu-Aggrey,
U. Huffmeier,
S. Uebe,
K. Steel,
H. Hébert,
C. Wallace,
Jonathon Massey,
I. Bruce,
J. Bluett,
M. Feletar,
A. Morgan,
H. Marzo-Ortega,
G. Donohoe,
D. Morris,
...
P. Helliwell,
A. Ryan,
D. Kane,
R. Warren,
E. Korendowych,
G. Alenius,
E. Giardina,
J. Packham,
R. McManus,
O. FitzGerald,
N. McHugh,
M. Brown,
P. Ho,
F. Behrens,
H. Burkhardt,
A. Reis,
A. Barton
|
8 |
2015 |
8 🐜
|
🐜
|
Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
32 auth.
J. Bowes,
A. Budu-Aggrey,
U. Huffmeier,
S. Uebe,
K. Steel,
H. Hébert,
C. Wallace,
J. Massey,
I. Bruce,
J. Bluett,
M. Feletar,
A. Morgan,
H. Marzo-Ortega,
G. Donohoe,
D. Morris,
...
P. Helliwell,
A. Ryan,
D. Kane,
R. Warren,
E. Korendowych,
G. Alenius,
E. Giardina,
J. Packham,
R. McManus,
O. FitzGerald,
N. McHugh,
M. Brown,
P. Ho,
F. Behrens,
H. Burkhardt,
A. Reis,
A. Barton
|
7 |
2015 |
7 🐜
|
🐜
|
Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)
7 auth.
E. Theander,
T. Husmark,
G. Alenius,
P. Larsson,
A. Teleman,
M. Geijer,
...
U. Lindqvist
|
7 |
2013 |
7 🐜
|
🦁
|
Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire.
G. Alenius,
B. Stenberg,
H. Stenlund,
M. Lundblad,
S. R. Dahlqvist
|
7 |
2002 |
7 🦁
|
🦁
|
Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation
G. Alenius,
E. Berglin,
S. R. Dahlqvist
|
6 |
2005 |
6 🦁
|
🐜
|
Diagnostic properties of metabolic perturbations in rheumatoid arthritis
8 auth.
Rasmus K Madsen,
T. Lundstedt,
Jon Gabrielsson,
C. Sennbro,
G. Alenius,
Thomas Moritz,
...
S. Rantapää-Dahlqvist,
J. Trygg
|
6 |
2011 |
6 🐜
|
🐬
|
The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
U. Lindqvist,
G. Alenius,
T. Husmark,
E. Theander,
G. Holmström,
P. Larsson
|
6 |
2008 |
6 🐬
|
🦁
|
Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?
G. Alenius,
C. Eriksson,
S. Rantapää Dahlqvist
|
6 |
2009 |
6 🦁
|
🐜
|
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus
24 auth.
J. Bowes,
Sabine Loehr,
A. Budu-Aggrey,
S. Uebe,
I. Bruce,
M. Feletar,
H. Marzo-Ortega,
P. Helliwell,
A. Ryan,
D. Kane,
...
E. Korendowych,
G. Alenius,
E. Giardina,
J. Packham,
R. McManus,
O. FitzGerald,
M. Brown,
F. Behrens,
H. Burkhardt,
N. McHugh,
U. Huffmeier,
P. Ho,
A. Reis,
A. Barton
|
6 |
2015 |
6 🐜
|